Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

BACKGROUND: Preoperative neoadjuvant chemotherapy (NACT) has been widely used in developing countries for the treatment of patients with International Federation of Gynecology and Obstetrics (FIGO) stages IB3 and IIA2 cervical cancer. However, the effectiveness of NACT and treatment options for NACT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yingjie, Han, Yingyan, Shen, Yuanming, Chen, Jing, Chen, Yaheng, Chen, Yile, Tang, Junying, Xue, Min, Hong, Li, Cheng, Wenjun, Wang, Danbo, Liang, Zhiqing, Wang, Yifeng, Zhang, Qinghua, Xing, Hui, Zhang, Yu, Yi, Cunjian, Yu, Zhiying, Chen, Youguo, Cui, Manhua, Ma, Cailing, Yang, Hongying, Li, Ruizhen, Long, Ping, Zhao, Yu, Qu, Pengpeng, Tao, Guangshi, Yang, Lihua, Wu, Sufang, Liu, Zhihua, Yang, Ping, Lv, Weiguo, Xie, Xing, Ma, Ding, Wang, Hui, Li, Kezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724322/
https://www.ncbi.nlm.nih.gov/pubmed/36471257
http://dx.doi.org/10.1186/s12885-022-10355-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724322/
https://www.ncbi.nlm.nih.gov/pubmed/36471257
http://dx.doi.org/10.1186/s12885-022-10355-3

Ejemplares similares